Individualized Choices in Antiretroviral Therapy: Present and Future

Download All
Download slides, read ClinicalThought faculty commentaries, or watch an on-demand video from this engaging satellite presented in conjunction with EACS 2021. Gain expert insights on providing optimal individualized care for patients with HIV today and in the future.
Jean-Michel Molina, MD, PhD
Cristina Mussini, MD
Chloe Orkin Photo
Chloe Orkin, MBChB, FRCP, MD
person default
Silvia Petretti


Here’s why patients need to be placed front and center when choosing antiretroviral therapy.

person default Silvia Petretti Released: October 22, 2021

Here’s why I think the 3 most essential aspects when switching ART are treatment history, genetic barrier to resistance, and hearing what your patient is telling you.

Chloe Orkin Photo Chloe Orkin, MBChB, FRCP, MD Released: November 24, 2021

Here are my thoughts on how the emergence of long-acting ART reflects the continued evolution of HIV treatment to better meet the broad needs of our patients and what ongoing research efforts may bring about for future long-acting ART options.

Jean-Michel Molina, MD, PhD Released: November 30, 2021

How soon should ART be initiated in patients who present with opportunistic infections, and what is the best regimen? In this commentary, I share my approach to starting ART in patients with advanced HIV and opportunistic infections.

Cristina Mussini, MD Released: December 13, 2021
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings